Lesson
Treat the Syndrome as a Neurologic Emergency
Bacterial invasion of the subarachnoid space triggers inflammation, edema, altered cerebral perfusion, and systemic illness. The classic triad is useful when present, but its absence does not make the syndrome safe.
- Fever
- Headache
- Neck stiffness
- Altered mental status
- Meningococcemia
Use tempo, host, neurologic findings, rash, and systemic severity.
Secure airway, stop seizure, and restore perfusion.
Preserve organism evidence without creating delay.
Start an effective central nervous system regimen.
Recognize variable presentation
Fever, headache, neck stiffness, and altered mental status are common, but infants, older adults, immunocompromised people, and patients pretreated with antibiotics can present less typically.
Link inflammation to injury
Cytokine-driven permeability, vasogenic and cytotoxic edema, impaired cerebrospinal fluid flow, vasculopathy, and reduced cerebral perfusion can produce seizure, infarction, cranial neuropathy, or herniation.
Identify meningococcal sepsis
A rapidly progressive petechial or purpuric rash, shock, severe limb pain, or capillary leak can accompany meningococcemia. Stabilization and antimicrobial treatment cannot wait for meningeal signs.
Protect the first hour
Airway compromise, shock, uncontrolled seizure, or rapidly spreading purpura takes priority over lumbar puncture. Obtain cultures when feasible, but do not let a procedure or image become an antibiotic gatekeeper.
Quick check
Lesson
Preserve Diagnostic Yield Without Delaying Treatment
Blood cultures and cerebrospinal fluid can identify the organism and support narrowing. They should be collected before antibiotics when safe and immediately feasible, but treatment begins when lumbar puncture or imaging would cause meaningful delay.
- Blood cultures
- Lumbar puncture
- Computed tomography
- Polymerase chain reaction
- Antibiotic timing
Obtain cultures promptly when access is available.
Identify instability, bleeding, or mass-effect concern.
Perform lumbar puncture promptly when safe.
Treat while imaging or procedures remain pending.
Obtain blood before therapy
Collect blood cultures and relevant laboratory tests promptly because blood may remain diagnostic even when lumbar puncture is unsafe or delayed.
Perform lumbar puncture promptly
When no contraindication or deferral reason exists, lumbar puncture should occur as soon as possible, preferably before antibiotics. Record opening pressure and send cell count with differential, glucose with paired serum glucose, protein, Gram stain, culture, and molecular tests available locally.
Image selectively
Computed tomography before lumbar puncture is not routine. Focal neurologic deficit, abnormal pupillary response, severe consciousness impairment, signs of mass effect, or another defined concern may justify imaging, but antibiotics continue on schedule.
Interpret tests after pretreatment
Antibiotics can reduce culture yield. Cell profile, glucose ratio, protein, blood cultures, polymerase chain reaction, and the clinical trajectory remain useful, so a negative culture does not automatically exclude treated bacterial meningitis.
Quick check
Lesson
Read Cerebrospinal Fluid as a Pattern
Bacterial meningitis often produces neutrophilic pleocytosis, elevated protein, and reduced cerebrospinal fluid glucose relative to blood. Early disease, immunocompromise, partial treatment, and organism biology can blur that pattern.
- Opening pressure
- Neutrophils
- Protein
- Glucose ratio
- Gram stain and culture
Record the value and technical context.
Neutrophils support but do not define the diagnosis.
Pair cerebrospinal fluid glucose with blood glucose.
Combine stain, culture, molecular testing, and susceptibility.
Use the glucose relationship
A low cerebrospinal fluid glucose concentration is more meaningful when interpreted against a paired blood glucose because systemic hyperglycemia changes the absolute value.
Integrate cell count and protein
Neutrophilic pleocytosis and elevated protein support bacterial inflammation, but a lymphocytic pattern can occur later or with selected organisms, and a weak cellular response can occur in severe immunosuppression.
Value direct organism tests
Gram stain, culture, and validated molecular assays help identify the cause. Culture also enables susceptibility testing, which is essential when narrowing resistant pneumococcus or meningococcus.
Avoid false reassurance
Normal or near-normal values early in illness do not always exclude disease. If suspicion remains high, continue urgent management and involve infectious diseases or neurology for repeat or expanded testing.
Quick check
Lesson
Let Age and Host Biology Predict the Missing Organism
Streptococcus pneumoniae and Neisseria meningitidis dominate many community-acquired presentations, but the pathogen set changes with age, immune state, pregnancy, anatomy, devices, surgery, and exposure.
- Pneumococcus
- Meningococcus
- Haemophilus influenzae
- Listeria monocytogenes
- Healthcare-associated infection
Pneumococcus, meningococcus, and Haemophilus remain central.
Age over 60, pregnancy, or immunocompromise changes therapy.
Use a neonatal pathogen and safety pathway.
Neurosurgery and devices require healthcare-associated coverage.
Start with community pathogens
Pneumococcus, meningococcus, and Haemophilus influenzae remain core considerations, shaped by age, vaccination, epidemiology, and source.
Recognize Listeria risk
The 2025 WHO guideline identifies age over 60 years, pregnancy, and immunocompromise as major reasons to add ampicillin or amoxicillin. A cephalosporin alone does not reliably cover Listeria.
Separate neonatal disease
Newborn meningitis has distinct pathogens, dosing, bilirubin, calcium, renal, and developmental considerations. It requires a neonatal protocol and specialist care rather than an adult regimen scaled by weight.
Route healthcare-associated disease elsewhere
Recent neurosurgery, penetrating trauma, cerebrospinal fluid shunt, drain, or hardware changes the likely organisms and empiric spectrum. This module centers community-acquired disease and signals those cases for a dedicated pathway.
Quick check
Lesson
Build Empiric Therapy From Required Coverage
Current WHO guidance recommends intravenous ceftriaxone or cefotaxime for suspected acute bacterial meningitis. Add ampicillin or amoxicillin for Listeria risk, and consider vancomycin where resistant pneumococcus makes cephalosporin monotherapy unreliable.
- Ceftriaxone
- Cefotaxime
- Ampicillin
- Vancomycin
- Resistance context
Use ceftriaxone or cefotaxime at a meningitis regimen.
Add for current Listeria risk.
Consider when resistant pneumococcus threatens the anchor.
Remove unnecessary coverage when evidence arrives.
Anchor the regimen
A third-generation cephalosporin supplies broad initial activity against common community pathogens and must be delivered intravenously at a meningitis regimen rather than a routine infection dose.
Add Listeria coverage deliberately
Ampicillin or amoxicillin is added when age over 60 years, pregnancy, or immunocompromise raises Listeria risk. This is additional coverage, not a substitute for the cephalosporin.
Place vancomycin by epidemiology
WHO conditionally recommends considering intravenous vancomycin where penicillin-resistant or third-generation cephalosporin-resistant pneumococcus is prevalent. Local resistance, patient history, and institutional policy refine this choice.
Escalate severe allergy
A severe immediate or severe delayed beta-lactam reaction requires expert selection and close monitoring. The correct alternative depends on the reaction, likely organisms, age, pregnancy, local susceptibility, and available agents.
Quick check
Lesson
Place Dexamethasone Before the Inflammatory Surge
Adjunctive dexamethasone can reduce selected neurologic complications when started with or before the first antibiotic dose. It never justifies delaying antibiotics, and continuation depends on age, organism, timing, and specialist guidance.
- Adjunctive therapy
- First antibiotic dose
- Pneumococcus
- Haemophilus influenzae type b
- Glucose and gastrointestinal safety
Give dexamethasone before or with antibiotics when possible.
Never postpone the antimicrobial dose.
Continue for pneumococcus or Haemophilus type b.
Follow glucose, gastrointestinal risk, and clinical course.
Use the correct sequence
For people over 3 months with strongly suspected or confirmed bacterial meningitis, NICE recommends intravenous dexamethasone. Give it with or before the first antibiotic if possible, but never hold antibiotics while waiting.
Handle a delayed start
If dexamethasone is delayed less than 12 hours after antibiotics, NICE recommends giving it as soon as possible. After a longer delay, obtain infection specialist advice because benefit is less certain.
Reassess after identification
NICE recommends continuing dexamethasone for pneumococcus or Haemophilus influenzae type b and stopping it for other identified organisms. When no organism is found, specialist judgment guides continuation.
Monitor the adjunct
Review hyperglycemia, gastrointestinal bleeding risk, mental status, infection course, and other corticosteroid effects. The meningitis use is off-label in the NICE guideline and should follow the institution's current protocol.
Quick check
Lesson
Narrow From Organism, Susceptibility, and Response
Definitive therapy is not simply the narrowest named drug. It must reach cerebrospinal fluid at an effective regimen, match susceptibility, treat the organism for an appropriate duration, and respond to clinical progress and source control.
- Susceptibility
- De-escalation
- Duration
- Carriage eradication
- Repeat evaluation
Use culture or validated molecular identification.
Confirm that the narrowed agent is active.
Match course to organism, source, and response.
Address meningococcal eradication before discharge.
Use current susceptibility
For meningococcus, current CDC guidance keeps ceftriaxone or cefotaxime active initially. Penicillin G or ampicillin is appropriate only after susceptibility is confirmed because resistant and beta-lactamase-producing isolates have emerged.
Match duration to cause
WHO tables describe typical ranges such as 5 to 7 days for meningococcus, 7 to 10 days for Haemophilus influenzae, 10 to 14 days for pneumococcus, and at least 21 days for Listeria, then require clinical and microbiologic context.
Reassess failure
Persistent fever, worsening consciousness, new focal findings, seizure, unstable physiology, resistant organism, abscess, parameningeal focus, endocarditis, hardware, or uncertain diagnosis should trigger renewed imaging, source, susceptibility, and specialist review.
Close the meningococcal carriage loop
Ceftriaxone clears nasopharyngeal carriage effectively. If treatment did not use ceftriaxone or cefotaxime, CDC recommends an eradication regimen before discharge using an appropriate prophylaxis option.
Quick check
Lesson
Treat the Central Nervous System Exposure, Not Just the Vial
Meningitis requires high-dose intravenous regimens designed for cerebrospinal fluid exposure. Age, renal function, body size, infusion conditions, inflammation, and product-specific contraindications can change both exposure and harm.
- Meningitis regimen
- Renal function
- Vancomycin monitoring
- Neonatal ceftriaxone
- Administration safety
Do not reuse a routine infection dose.
Recalculate through renal and volume changes.
Use the institution's serum exposure method.
Honor ceftriaxone bilirubin and calcium contraindications.
Use indication-specific dosing
A routine pneumonia or urinary infection dose may be inadequate for meningitis. Use the current institutional meningitis protocol and current product information rather than memory from a different syndrome.
Individualize vancomycin
Renal function, body size, critical illness, changing volume, concurrent nephrotoxins, and institutional serum-exposure methods shape vancomycin dosing. Central nervous system penetration is variable and does not remove toxicity monitoring.
Protect neonates from ceftriaxone hazards
Current labeling contraindicates ceftriaxone in premature neonates, hyperbilirubinemic neonates, and neonates 28 days or younger who require or are expected to require calcium-containing intravenous solutions. Neonatal therapy belongs to a separate protocol.
Recalculate through the course
Kidney function, fluid balance, extracorporeal support, clinical recovery, and inflammation can change during treatment. Reassess dose and monitoring after major physiologic transitions rather than copying the admission order forward.
Quick check
Lesson
Treat the Brain, the Circulation, and the Recovery
Antibiotics address the pathogen while supportive care prevents secondary injury. Shock, hypoxemia, seizure, cerebral edema, sodium disorders, thrombosis, hearing loss, and neurocognitive disability require parallel surveillance.
- Sepsis
- Seizure
- Intracranial pressure
- Fluid strategy
- Hearing and neurologic outcomes
Avoid shock, hypotension, and hypoxemia.
Escalate pupil, consciousness, focal, or seizure change.
Treat the actual volume and electrolyte disorder.
Plan hearing, cognition, mobility, and rehabilitation.
Resuscitate physiology
Follow current sepsis principles for airway, oxygenation, perfusion, lactate, fluids, vasoactive support, and source evaluation while avoiding hypotension and hypoxemia that worsen cerebral injury.
Manage neurologic deterioration
New anisocoria, focal deficit, declining consciousness, recurrent seizure, or Cushing physiology requires urgent critical-care and neurologic assessment. Routine osmotic therapy is not a substitute for diagnosing the cause.
Avoid reflexive fluid restriction
NICE advises against routine fluid restriction below maintenance needs. Sodium and volume abnormalities require diagnosis because dehydration, shock, SIADH, cerebral salt wasting, and kidney dysfunction have different treatments.
Plan beyond survival
Arrange hearing assessment and evaluate neurologic, cognitive, behavioral, communication, mobility, school, work, and rehabilitation needs. Explain that recovery can continue after discharge and complications may emerge later.
Quick check
Lesson
Close the Public Health and Longitudinal Loops
Suspected meningococcal disease requires droplet precautions, prompt public health coordination, and rapid prophylaxis for defined close contacts. Survivors also need recurrence-risk, vaccination, hearing, neurologic, and psychosocial follow-up.
- Droplet precautions
- Close contacts
- Chemoprophylaxis
- Resistance
- Recurrence risk
Continue until 24 hours of effective therapy.
Build the close-contact list immediately.
Choose quickly by exposure, life stage, and resistance.
Review complement, spleen, HIV, leak, and vaccines.
Define meaningful exposure
Household members, childcare contacts, and people directly exposed to oral or respiratory secretions are typical close contacts. Healthcare personnel generally need prophylaxis only after airway management or respiratory secretion exposure, not routine room entry.
Act quickly
CDC recommends prophylaxis as soon as possible, ideally within 24 hours of identifying the index patient. Prophylaxis given more than 14 days after illness onset is likely to have little or no value.
Choose with resistance and life stage
Rifampin, ceftriaxone, and ciprofloxacin are accepted options, but age, pregnancy, interactions, adherence, and local ciprofloxacin resistance change the choice. Ceftriaxone is the preferred option described by CDC for pregnancy.
Investigate recurrence risk
Recurrent meningococcal disease can signal complement deficiency or complement inhibitor exposure. Asplenia, HIV, anatomic cerebrospinal fluid leak, vaccination gaps, and other immune conditions can alter prevention and follow-up.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 172 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.